InsidersTradesSigma
Follow the Apyx Medical Corp share price and the full directors' dealings record of the company, a publicly traded company based in United States. Shares are listed on the US market, under the authority of SEC (Form 4). Operating in the Health Care sector, Apyx Medical Corp has logged 24 insider filings. Market capitalisation: €165.1m. The latest transaction was disclosed on 2 July 2026 (Levée d'options). Among the most active insiders: Waldman Lawrence. The full history is accessible without an account.
24
Insider Decl.
n/a
Thresholds
€101,929
5 ops.
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Apyx Medical Corp Strong Buy (bullish), based on 5 analysts. Average price target: US$6.60.
46Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 25,172 of 28,717 companies
24.3
score / 100
Value18
Quality30
FCF yld-6.9%
Earn yld-8.5%
EV/EBITDA·
ROE-91%
Gross mgn63%
Net mgn-21%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 2 July 2026
Declarations24 total
12,000 sharesCommon StockSEC:0001493152-26-031944:0
5,024 sharesCommon StockSEC:0001493152-26-031944:1
15,000 sharesCommon StockSEC:0001493152-26-029122:0
10,533 sharesCommon StockSEC:0001493152-26-029122:1
450,000 sharesRestricted Stock UnitsSEC:0001493152-26-028771:0
37,000 shares@ US$1.8043.3% of flowCommon StockSEC:0001493152-26-010632:0
12,000 shares@ US$1.80100.0% of flowCommon StockSEC:0001493152-26-004254:0
6,000 shares@ US$1.1336.8% of flowCommon StockSEC:0001493152-25-008863:0
Canonical exit: 11 Nov 2024 (T+90)
5,336 shares@ US$1.1332.8% of flowCommon StockSEC:0001493152-24-031725:0
Canonical exit: 11 Nov 2024 (T+90)
2,500 shares@ US$2.1930.4% of flowCommon StockSEC:0001493152-23-044805:0
Canonical exit: 11 Mar 2024 (T+90)
50,000 shares@ US$1.5786.1% of flowCommon StockSEC:0001493152-23-041501:0
Canonical exit: 12 Feb 2024 (T+90)
5,338 shares@ US$2.9714.8% of flowCommon StockSEC:0001493152-23-024899:0
15,000 shares@ US$1.7750.0% of flowCommon StockSEC:0000719135-23-000040:0
15,000 shares@ US$1.7750.0% of flowCommon StockSEC:0000719135-23-000036:0
10,000 shares@ US$2.7950.2% of flowCommon StockSEC:0000719135-23-000030:0
7,173 shares@ US$9.4243.8% of flowCommon StockSEC:0000719135-23-000020:0
2,000 shares@ US$5.9313.9% of flowCommon StockSEC:0000719135-22-000084:0
Canonical exit: 27 Nov 2022 (T+90)
30,000 shares@ US$2.54100.0% of flowCommon StockSEC:0000719135-22-000055:0
4,000 shares@ US$2.5419.2% of flowCommon StockSEC:0000719135-22-000050:0
30,000 shares@ US$2.54100.0% of flowCommon StockSEC:0000719135-22-000052:0
24,000 shares@ US$2.5463.2% of flowCommon StockSEC:0000719135-22-000053:0
8,000 shares@ US$2.790.013% mcap100.0% of flowCommon StockSEC:0000719135-22-000037:0
6,000 shares@ US$2.790.0096% mcap100.0% of flowCommon StockSEC:0000719135-22-000035:0
17,000 shares@ US$4.980.046% mcap100.0% of flowCommon StockSEC:0000719135-22-000024:0
24 of 24 declarations
About Apyx Medical Corp
Apyx Medical Corp is a company focused on developing medical technologies, including surgical and skin care devices. It emphasizes innovation in the healthcare and pharmaceutical sectors.